ヨーロッパの抗うつ薬市場は2023年に約45億米ドルと評価され、2024年から2032年の予測期間にわたって2.85%を超える健全な成長率で成長すると予想されています。
抗うつ薬は、うつ病の症状を緩和するために開発された薬です。脳内の神経伝達物質、つまり神経細胞間で信号を伝達する化学物質のバランスに影響を与えることで作用します。これらの薬は、持続的な悲しみ、活動への興味の欠如、集中力の低下などのうつ病の症状を緩和するのに役立ちますが、その効果と副作用は個人によって異なります。さらに、精神衛生問題を取り巻く認識が高まり、偏見が減少しました。これにより、大うつ病性障害、不安障害、その他の気分障害などの症状の診断と治療が増加しました。メンタルヘルスに焦点を当てた政府の取り組みや政策が、ヨーロッパの抗うつ薬市場に魅力を与えています。
ヨーロッパの抗うつ薬市場は、うつ病や不安などの精神疾患の罹患率の増加によって牽引されており、これらの疾患の治療を求める人が増えていることが大きな要因となっています。さらに、医薬品の研究開発の進歩も市場の成長を後押ししており、これにより、より効果的な新しい抗うつ薬の導入が増加し、成長にプラスの影響を与えるでしょう。さらに、ヨーロッパでは人口が高齢化しており、地域全体で精神疾患の影響を受けやすくなっています。ただし、抗うつ薬に関連する副作用や、新しい抗うつ薬の厳格な規制、および長期にわたる承認プロセスにより、2024年から2032年の予測期間中、市場全体の需要が抑制されることになります。
ヨーロッパの抗うつ薬市場調査で検討されている主要国には、イギリス、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ諸国が含まれます。2023年には、収益の面でドイツが最大の地域市場となりました。この国には、公的および民間の医療提供者によってサポートされている、精神疾患の診断と治療のための確立されたシステムがあります。さらに、ドイツのヘルスケアと製薬研究への多大な投資は、革新的な抗うつ薬の開発と利用可能性を促進しています。ドイツには大手製薬会社と研究機関があり、進歩を促進し、新しい効果的な治療法の安定した供給を確保しているため、この国が主導的な地位にあることにも貢献しています。さらに、一方、イギリスの市場は、2024年から2032年の予測期間にわたって最も速い速度で発展すると予想されています。
目次
Table of Contents
Chapter 1. Europe Antidepressant Drugs Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Europe Antidepressant Drugs Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By Depressive Disorder
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Antidepressant Drugs Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Antidepressant Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Antidepressant Drugs Market Size & Forecasts by Product 2022-2032
5.1. Tricyclic Antidepressants
5.2. Selective Serotonin Reuptake Inhibitors
5.3. Serotonin Norepinephrine Reuptake Inhibitors
5.4. Monoamine Oxidase Inhibitors
5.5. Serotonin Antagonist and Reuptake Inhibitors
5.6. Others
Chapter 6. Europe Antidepressant Drugs Market Size & Forecasts by Depressive Disorder 2022-2032
6.1. Major Depressive Disorder
6.2. Obsessive-Compulsive Disorder
6.3. Generalized Anxiety Disorder
6.4. Panic Disorder
6.5. Others
Chapter 7. Europe Antidepressant Drugs Market Size & Forecasts by Country 2022-2032
7.1. U.K. Antidepressant Drugs Market
7.1.1. Product breakdown size & forecasts, 2022-2032
7.1.2. Depressive Disorder breakdown size & forecasts, 2022-2032
7.2. Germany Antidepressant Drugs Market
7.3. France Antidepressant Drugs Market
7.4. Spain Antidepressant Drugs Market
7.5. Italy Antidepressant Drugs Market
7.6. Rest of Europe Antidepressant Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. GlaxoSmithKline plc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. AstraZeneca
8.3.3. Mallinckrodt
8.3.4. Novartis AG
8.3.5. Endo Pharmaceuticals plc
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Europe Antidepressant Drugs market, report scope
TABLE 2. Europe Antidepressant Drugs market estimates & forecasts by Country 2022-2032 (USD Billion)
TABLE 3. Europe Antidepressant Drugs market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 4. Europe Antidepressant Drugs market estimates & forecasts by Depressive Disorder 2022-2032 (USD Billion)
TABLE 5. Europe Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Europe Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Europe Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Europe Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Europe Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Europe Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Europe Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Europe Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Europe Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion) Europe Antidepressant Drugs market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. UK Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. UK Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 16. UK Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. Germany Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 18. Germany Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 19. Germany Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. France Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 21. France Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 22. France Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. Italy Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 24. Italy Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 25. Italy Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Spain Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 27. Spain Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 28. Spain Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. RoE Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 30. RoE Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 31. RoE Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. List of secondary sources, used in the study of Europe Antidepressant Drugs Market.
TABLE 33. List of primary sources, used in the study of Europe Antidepressant Drugs Market.
TABLE 34. Years considered for the study.
TABLE 35. Exchange rates considered
List of figures
FIG 1. Europe Antidepressant Drugs market, research methodology
FIG 2. Europe Antidepressant Drugs market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Antidepressant Drugs market, key trends 2023
FIG 5. Europe Antidepressant Drugs market, growth prospects 2022-2032
FIG 6. Europe Antidepressant Drugs market, porters 5 force model
FIG 7. Europe Antidepressant Drugs market, pestel analysis
FIG 8. Europe Antidepressant Drugs market, value chain analysis
FIG 9. Europe Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 10. Europe Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 11. Europe Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 12. Europe Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 13. Europe Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 14. Europe Antidepressant Drugs market, Country snapshot 2022 & 2032
FIG 15. Europe Antidepressant Drugs market 2022 & 2032 (USD Billion)
FIG 16. Europe Antidepressant Drugs market, company market share analysis (2023)
